SWTX vs. LLY
SWTX (SpringWorks Therapeutics, Inc.) and LLY (Eli Lilly and Company) are both stocks. Both are in the Healthcare sector — SWTX in Biotechnology, LLY in Drug Manufacturers - General. At a 0.16 correlation, their price movements are largely independent.
Performance
SWTX vs. LLY - Performance Comparison
Loading charts...
Returns By Period
SWTX
- 1D
- —
- 1M
- —
- YTD
- —
- 6M
- —
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
LLY
- 1D
- 1.37%
- 1M
- 11.64%
- YTD
- 0.72%
- 6M
- 4.73%
- 1Y
- 44.70%
- 3Y*
- 35.56%
- 5Y*
- 41.13%
- 10Y*
- 32.66%
SWTX vs. LLY - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
SWTX SpringWorks Therapeutics, Inc. | 0.00% | 30.06% | -1.01% | 40.33% | -58.03% | -14.53% | 88.41% | 70.08% |
LLY Eli Lilly and Company | 0.72% | 40.25% | 33.30% | 60.91% | 34.26% | 66.08% | 31.04% | 19.20% |
Correlation
The correlation between SWTX and LLY is -0.00, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.00 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Sep 16, 2019 | 0.16 |
The correlation between SWTX and LLY shifts across timeframes, from -0.00 (1 year) to 0.17 (3 years), reflecting how their relationship changes across market environments.
Fundamentals
SWTX:
$219.67M
LLY:
$72.25B
SWTX:
$204.80M
LLY:
$59.75B
SWTX:
-$263.55M
LLY:
$32.97B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SWTX vs. LLY — Risk / Return Rank
SWTX
LLY
SWTX vs. LLY - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SpringWorks Therapeutics, Inc. (SWTX) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| SWTX | LLY | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 1.19 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 1.26 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 1.09 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | — | 0.57 | — |
Drawdowns
SWTX vs. LLY - Drawdown Comparison
Loading charts...
Drawdown Indicators
| SWTX | LLY | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | — | -68.24% | — |
Max Drawdown (1Y)Largest decline over 1 year | — | -23.64% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -34.48% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -34.48% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -34.48% | — |
Current DrawdownCurrent decline from peak | — | -4.26% | — |
Average DrawdownAverage peak-to-trough decline | — | -19.22% | — |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 9.49% | — |
Volatility
SWTX vs. LLY - Volatility Comparison
Loading charts...
Volatility by Period
| SWTX | LLY | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 9.16% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 26.81% | — |
Volatility (1Y)Calculated over the trailing 1-year period | — | 37.88% | — |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | — | 32.79% | — |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | — | 30.14% | — |
Dividends
SWTX vs. LLY - Dividend Comparison
SWTX has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.60%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LLY Eli Lilly and Company | 0.60% | 0.56% | 0.67% | 0.78% | 1.07% | 1.23% | 1.75% | 1.96% | 1.94% | 2.46% | 2.77% | 2.37% |
SWTX SpringWorks Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
SWTX vs. LLY - Financials Comparison
This section allows you to compare key financial metrics between SpringWorks Therapeutics, Inc. and Eli Lilly and Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
SWTX and LLY have a correlation of -0.00, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for SWTX and LLY
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer